Evidence map›Paper›PMID 39391549›Full record

ArticleCirculation reports2024

Novel Method for Risk Stratification of Major Adverse Clinical Events Using Pre- and Post-Ablation Left Atrial Volume Index in Patients With Persistent Atrial Fibrillation.

Hironori Ishiguchi, Yasuhiro Yoshiga, Akihiko Shimizu, Masakazu Fukuda, Ayumi Omuro, Masahiro Hisaoka, Yusuke Nakashima, Miho Fujita, Shintaro Hashimoto, Takuya Omuro and 4 more

Abstract read
In one paragraph

Article in Circulation reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Hironori IshiguchiDivision of Cardiology, Department of Medicine and Clinical Science, Yamaguchi University Graduate School of Medicine Yamaguchi Japan.
Yasuhiro YoshigaDivision of Cardiology, Department of Medicine and Clinical Science, Yamaguchi University Graduate School of Medicine Yamaguchi Japan.
Akihiko ShimizuDepartment of Cardiology, Ube-Kohsan Central Hospital Yamaguchi Japan.
Masakazu FukudaDivision of Cardiology, Department of Medicine and Clinical Science, Yamaguchi University Graduate School of Medicine Yamaguchi Japan.
Ayumi OmuroDivision of Cardiology, Department of Medicine and Clinical Science, Yamaguchi University Graduate School of Medicine Yamaguchi Japan.
Masahiro HisaokaDivision of Cardiology, Department of Medicine and Clinical Science, Yamaguchi University Graduate School of Medicine Yamaguchi Japan.
Yusuke NakashimaDivision of Cardiology, Department of Medicine and Clinical Science, Yamaguchi University Graduate School of Medicine Yamaguchi Japan.
Miho FujitaDivision of Cardiology, Department of Medicine and Clinical Science, Yamaguchi University Graduate School of Medicine Yamaguchi Japan.
Shintaro HashimotoDivision of Cardiology, Department of Medicine and Clinical Science, Yamaguchi University Graduate School of Medicine Yamaguchi Japan.
Takuya OmuroDepartment of Medicine and Clinical Science, Faculty of Health Sciences, Yamaguchi University Graduate School of Medicine Yamaguchi Japan.
Toru AriyoshiUltrasound Examination Center, Yamaguchi University Hospital Yamaguchi Japan.
Shigeki KobayashiDepartment of Therapeutic Science for Heart Failure in the Elderly, Yamaguchi University Graduate School of Medicine Yamaguchi Japan.
Takayuki OkamuraDivision of Cardiology, Department of Medicine and Clinical Science, Yamaguchi University Graduate School of Medicine Yamaguchi Japan.
Motoaki SanoDivision of Cardiology, Department of Medicine and Clinical Science, Yamaguchi University Graduate School of Medicine Yamaguchi Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: The relationship between changes in the left atrial volume index (LAVI) post-catheter ablation (CA) and long-term prognostic events in patients with persistent atrial fibrillation (AF) remains unclear. We evaluated the incidence of major adverse clinical events (MACE), including all-cause death, unplanned heart failure hospitalization, and unplanned cardiovascular hospitalization using pre- and post-CA LAVI. Methods and Results: We collected data retrospectively from 150 patients with persistent AF who underwent their first CA. LAVI was calculated during preprocedural echocardiography under AF rhythm (pre-CA LAVI) and 3 months post-CA under sinus rhythm (post-CA LAVI). The cumulative incidence of MACE was compared among 3 subgroups based on the cutoff values of pre-CA (45.5 mL/m Conclusions: Combining pre-CA and post-CA LAVIs is valuable in stratifying long-term MACE development risk following CA.

Indexed as

Atrial fibrillationCatheter ablationHeart failureLeft atrial volume indexMajor adverse clinical events

Identifiers

PMID39391549
PMCPMC11464015

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.